The study of ocular biomarkers is a complex process. As one of the industry leaders in the field of ophthalmology, Ace Therapeutics is pleased to provide global customers with ocular candidate biomarker optimization services. Through high-throughput detection technology and powerful bioinformatics software, we can customize suitable programs for customers in a short period of time, and obtain ideal ocular biomarkers with both accuracy and reproducibility through strict program execution processes, to meet the research needs of customers.
Candidate biomarkers are generally selected from a large number of samples, and are measurable substances with differential expression characteristics in two or more types of samples. In theory, the number of candidate biomarkers screened in preliminary studies is more than one. As a result, researchers must optimize it and narrow the range of biomarkers in order to move to the next phase more quickly. In the process of biomarker development, an ideal biomarker needs to pass through many steps from initial discovery to final clinical application. Optimization of candidate biomarkers is an essential step. Since candidate biomarkers do not always fit the profile of a reasonable biomarker, further optimization steps are required to find biomarkers specifically associated with certain disease states or physiological states, which typically require detection devices with high specificity, high sensitivity, and short sample preparation time and corresponding bioinformatics analysis are used for processing. Optimized candidate biomarkers because of their specificity are more likely to guide drug discovery and inform clinical translation.
Ace Therapeutics has a team of dedicated ophthalmology researchers and biomarkers who are committed to contributing to the ophthalmology research of its partners. Here, we provide global customers with high-quality ocular biomarker optimization services to pave the way for later-stage research.
Relying on our experienced multi-omics services and powerful bioinformatics analysis software, we provide our clients with high-quality, interpretable results. Advance your ophthalmic drug discovery with our highly flexible and customizable platform, and benefit from our long-standing experience in analyzing preclinical research samples. Our ocular candidate biomarkers are mostly designed according to the customer's project requirements, possible drug mechanisms of action, and in vivo and in vitro experimental verification. They include but are not limited to:
Ace Therapeutics' ocular biomarker research team provides global customers with high-quality customized services related to ocular biomarker candidates. Our scientists can customize scientific and rigorous laboratory plans according to the research needs and sample types of customers. If you are looking for related services, Ace Therapeutics may be your ideal partner. Please feel free to contact us for more information.